Caprock Group’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
FAM
AIM
MCMC
CC
Caprock Group's CDNA Position: Q3 2021 in Review
Caprock Group sold out of CareDx (CDNA) in Q3 2021, closing a stake of 2,980 shares — an estimated $273K sold.
Caprock Group first reported a position in CDNA in Q3 2018 and held it in 7 quarters. The position peaked at $326K in Q4 2020. 260 funds tracked by Wall St. Rank hold CDNA as of Q3 2021.
- Caprock Group reported no remaining CareDx position as of Q3 2021 after selling out during the quarter.
- Caprock Group sold 2,980 CareDx shares in Q3 2021, an estimated $273K.
- Caprock Group first reported a position in CareDx in Q3 2018 and held it in 7 quarters.
- Caprock Group's CareDx position peaked at $326K in Q4 2020.
- 260 funds tracked by Wall St. Rank held CareDx as of Q3 2021.
Based on Caprock Group's 13F filing for Q3 2021, filed 7 Oct 2021.